Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Clinical trial NCT03709082 · TERMINATED
Trial details
- NCT number
- NCT03709082
- Sponsor
- University of Kansas Medical Center
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2020-03-12
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.